Loading
Latest filing published 27 Mar 2018 for Cardiome Pharma Corp., €12k.
Justin Renz is a declared insider of Cardiome Pharma Corp., with filings sourced from SEDI. Between 24 August 2017 and 26 March 2018, the trades on record add up to 2 filings.
Purchases make up the whole of the open-market record (2 purchases, €28k). Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. In 2018 alone, the filings show 1 purchase and no sales.
The record was last updated on 27 March 2018 with an open-market purchase (€12k) in Cardiome Pharma Corp. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations